Two Sigma Investments, LP Harpoon Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.82 $7,664 - $11,427	-13,936 Reduced 24.41%	43,144 $30,000
Q1 2023 May 15, 2023	BUY	$0.65 - $1.37 $37,102 - $78,199	57,080 New	57,080 $42,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $2.56 $13,300 - $36,221	14,149 Added 73.65%	33,361 $32,000
Q2 2022 Aug 15, 2022	BUY	$1.78 - $5.02 $34,197 - $96,444	19,212 New	19,212 $37,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $415,744 - $948,931	-117,442 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $1.64 Million - $2.26 Million	-289,028 Reduced 71.11%	117,442 $887,000
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $3.2 Million - $5.69 Million	406,470 New	406,470 $3.21 Million
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $369,504 - $513,792	-28,800 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$11.01 - $18.52 $2,444 - $4,111	-222 Reduced 0.76%	28,800 $489,000
Q2 2020 Aug 14, 2020	SELL	$11.11 - $24.72 $124,543 - $277,111	-11,210 Reduced 27.86%	29,022 $482,000
Q1 2020 May 15, 2020	BUY	$10.74 - $16.32 $7,313 - $11,113	681 Added 1.72%	40,232 $466,000
Q4 2019 Feb 14, 2020	BUY	$12.94 - $20.58 $511,789 - $813,959	39,551 New	39,551 $585,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.